We are pleased to highlight an important milestone achieved within the PIPELINE-RSV project, an international collaboration dedicated to advancing research on respiratory syncytial virus (RSV) in babies and pregnant women.
The project has received its first regulatory green light in the United Kingdom, enabling St George’s Hospital in London to be officially activated as the first study site. With this activation, recruitment can begin—marking a significant early step for the consortium leading the study.
As a contributing partner, conect4children Stichting supports the project’s efforts to strengthen paediatric research infrastructure and facilitate high‑quality, child‑centred clinical studies across Europe. This milestone reflects the strong coordination between clinical teams, academic experts, research networks, and industry partners working together to improve the evidence base for RSV prevention and care.
Additional European study sites are expected to open soon, further expanding the reach and impact of the PIPELINE trial.
Cookie policy